KathrynMargaret(Jenkins)HaiderMD

Ophthalmology • Indianapolis, IN

Pediatric & Strabismus

Associate Professor of Ophthalmology

Join to view full profile

Dr. Haider is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haider's full profile

Already have an account?

Office
705 Riley Hospital Dr
Indianapolis, IN 46202
Phone+1 317-274-2128

Education & Training

SSM Health/Saint Louis University School of MedicineResidency, Ophthalmology, 2004 - 2007
Gundersen Lutheran Medical FoundationInternship, Transitional Year, 2003 - 2004
University of Wisconsin School of Medicine & Public HealthClass of 2003

Certifications & Licensure

IA State Medical License 2014 - 2025
IN State Medical License 2007 - 2025
American Board of Ophthalmology Ophthalmology

Clinical Trials

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP Start of enrollment: 2022 Apr 27
Terminated
Phase 3
Roles: Contact
Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Recruiting
Phase 2
Roles: Contact
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching Start of enrollment: 2020 Dec 08
Recruiting
Not Applicable
Roles: Contact

Publications & Presentations

PubMed

Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity.
Robert Minturn, Kelly Hartigan, Sravanthi Vegunta, Charline Boente, Lilian Golzarri-Arroyo
BMC Ophthalmology. 2024-05-24
1 citations
Outcomes and Complications 5 Years After Surgery for Pediatric Cataract Associated With Persistent Fetal Vasculature.
Kathryn M Haider, Michael X Repka, Desirae R Sutherland, Sarah R Hatt, Nicole Fallaha
American Journal of Ophthalmology. 2024-04-01
Comparing reactivation and retreatment for three doses of bevacizumab in type 1 retinopathy of prematurity.
Jay Chopra, Kathryn M Haider, Charline S Boente
Journal of AAPOS. 2024-04-01

Journal Articles

Using Adult Drug Efficacy Data to Aid in Interpretation of Underpowered Pediatric Studies
Kathryn (Jenkins) Haider, MD, JAMA Ophthalmology

Press Mentions

Bruce W. Peters, DO, an Otolaryngologist with Ocean ENT OtolaryngologyDecember 20th, 2021
Parents Concerned About Eye Strain with Increased Screen Time During E-learningAugust 25th, 2020
A Tiered Approach to Retinopathy of Prematurity Screening (TARP) Using a Weight Gain Predictive Model and a Telemedicine SystemJanuary 5th, 2017